Study to Evaluate the Safety and Efficacy of PB-201 in Treatment-naive Patients With Type 2 Diabetes Mellitus

NCT05102149 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

672

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM)

Interventions

DRUG: PB-201
DRUG: Vildagliptin
DRUG: PB-201 matched placebo
DRUG: Vildagliptin matched placebo

Sponsor

PegBio Co., Ltd.